Clinical Trial Update: Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 trial evaluated relative bioavailability of ropinirole implants versus oral ropinirole in Parkinson's disease patients on L-Dopa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ropinirole (oral) (ropinirole)
• Ropinirole implant (ropinirole)

Snippet

Sponsor: Titan Pharmaceuticals | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-05-06